Eric Thomas is the Founder, President and CEO of FreedomVoice. He brings to the team more than 16 years of leadership in the development of virtual and hosted business phone solutions. As a pioneer of toll free virtual phone systems in 1996, Thomas made his move towards the hosted VoIP phone system market in the year 2006. He made it his goal to provide a better set of telecommunications tools that small and medium sized businesses could use in order to enhance their image, as well as to maximize productivity. Not content to buy or borrow someone else’s technology, Thomas led FreedomVoice in the creation of FreedomIQ, an industry-leading hosted VoIP PBX platform engineered from the ground up.
Thomas is responsible for keeping FreedomVoice running as a profitable, privately held, debt-free, and rapidly-growing company by attracting customers with a friendly, down-to-earth staff. Applying a unique and cost-effective billing model, he ensures that FreedomVoice is committed to delivering an outstanding quality of service.
Before FreedomVoice, Thomas held the title of President at B/T SciTech, a molecular biology distribution firm that he founded back in 1991.
Adam Gould is currently CEO of Sensinode, which is a world leading provider of software for the Internet of Things. Adam has over 24 years of experience within the wireless industry. In addition, has also has extensive experience in leading engineering development teams, managing organizations and budgets of all sizes, creating technology strategies, contract negotiation, and leading business development, marketing and sales activities. Adam joined NextWave back in 2005, and was the GM of the business unit where he developed consumer products around NextWave semiconductor products. Adam also held title of Senior Vice President for semiconductor in Sales and Marketing. His previous role at Nextwave was SVP Product Development making him responsible for consumer product development, product planning, product management, program management and business development. Prior to joining NextWave, Adam was Chief Technology Officer and VP of Engineering for Nokia Mobile Phones’ CDMA unit, where he worked for almost 13 years. In this role, he was responsible for setting the technology direction and strategy for the CDMA group, as well as managing all of the Nokia CDMA technology development, including all levels of SW development, RF and RFIC, and digital ASIC development. Adam grew this team from a starting point of 50 to over 450 engineers. Prior to his becoming CTO, he held various positions in management, signal processing, systems and software engineering development. Before joining Nokia, he was a member of the engineering team at Motorola that developed the world’s first GSM phone. There he developed all of the signal processing software for that product. Adam holds more than 7 patents, and has degrees in electrical and computer engineering from Drexel University and the Massachusetts Institute of Technology. He is currently on the Board of Directors or on the Advisory Board for several companies.
John M. Newsam
John M. Newsam holds BA Hons, MA and DPhil degrees in Chemistry from Oxford University. After 2 years as a Royal Society/JSPS Research Fellow in Sendai (Japan), he became a senior staff chemist at Exxon Corporate Research in New Jersey until head-hunted into a molecular simulation software company in San Diego, California. As a materials scientist, John has authored over 150 publications on zeolites, crystallography, materials simulation and high throughput experimentation, lectured extensively, both nationally and internationally. He has also been recognized by several awards, including the Corday-Morgan Medal. As a business innovator and entrepreneur, John has co-founded six companies which include Tioga Research, Inc. (in 2011), Bio4Front, Inc. (in 2008), fqubed (in 2002, acquired by Nuvo Research in 2005), Integrated Discovery Sciences Corporation (in 2001, acquired by Bio and Gene in 2005), hte Aktiengesellschaft (in 1999, acquired by BASF in 2008), and FreedomVoice Systems (in 1996). He has delivered undergraduate courses on entrepreneurship and business innovation at UC San Diego, and has been an Adjunct Professor at both UC Santa Barbara (Materials Department) and UCSD (Chemistry & Biochemistry Department). John currently serves as Chairman and CEO of Tioga Research.
Jim Schumacher graduated with a BS in Chemistry from MIT and MD from Duke University. He completed a residency in Radiology at UCSD, along with a Neuroradiology fellowship at Duke University. He is board certified in Radiology by the American Board of Radiology and by the Royal College of Physicians and Surgeons of Canada. After completing medical training, Jim was on staff for 11 years with Cape Canaveral Hospital in Cocoa Beach Florida. It was there that he served 2 years as Chief of Medical Services, and 4 years as Medical Director of the OpenMRI of Rockledge. In 2004, Jim moved to Whitefish, Montana where he has been on staff at Kalispell Regional Medical Center, as well as where he has served as Medical Director of the Imaging Center at Health Center Northwest, and served on the Board of Directors of Health Center Northwest and the Board of Directors of Flathead Physician’s Group. He has also been on the Board of Directors of Freedom Voice Systems, a telecommunications company based in San Diego, CA, since 2001.
Julie has experience in making start-ups successful by taking them to profitability and exiting via acquisition in the Life Science market place. Her most recent success story was with GeneGo Inc., www.genego.com, a pathway software and database company that was privately held and sold to Thomson Reuters (Scientific) Inc. www.thomsonreuters.com. Julie was on the Board of GeneGo, a shareholder and was responsible for sales, marketing, IT and technical support. Previously, Julie has helped Battelle, a billion dollar nonprofit organization spin out a commercial company called OmniViz that was acquired by BioWisdom. She has also held senior positions at Accelrys, www.accelrys.com Nature, www.nature.com and Genometrix. Julie helped fund FreedomVoice (www.freedomvoice.com) where she is currently both a shareholder and board member. Her angel fund, Bryant Thomas Ventures, has seeded companies such as www.aprioribeauty.com and Simulscribe now owned by Ditech (www.ditechcom.com). She is currently CEO of Bimini, LLC, www.BiminiHealth.com and the Bryant Consulting Group, www.Bryant-Consulting-Group.com.